Questionable value of attribution when interpreting adverse event data: A joint evaluation by North Central Cancer Treatment Group (NCCTG) and American College of Surgeons Oncology Group (ACOSOG).
   Google Scholar   
Citation:
J Clin Oncol vol 25 (18S ) abst 6511
Meeting Instance:
ASCO 2006
Year:
2007
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
Yes
Biospecimen:
No
SDC:
Yes
Parents:
None
Children:
315  
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA025224, U10 CA076001, CA-076001, CA-25224  
Corr. Author:
 
Authors:
               
Networks:
 
Study
ACOSOG-Z9001
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Bios3, Original Reports, Clinical Trials